About 4 Trademarks found for “ATRECA”

Biological assays consisting primarily of monoclonal antibodies, pre-made buffer concentrates, and chemical reagents for clinical use and scientific research in the fields of biological and diagnostic testing for industrial, scientific and research use; biological tissue cultures for research and scientific diagnosis use; antibodies reagents for research and scientific diagnosis use; combinations of antibodies for clinical use and scientific research in the fields of biological and diagnostic testing for industrial, scientific and research use

Biological assays for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; pharmaceutical preparations, namely biologics for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, namely, biologics and antibodies for the treatment of oncological disorders and conditions; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologic pharmaceutical preparations, namely, antibodies for use with diagnostic agents for the diagnosis of oncological diseases, disorders and conditions in humans; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease

Research, design and development of diagnostics for predicting the response of patients to therapeutics; research, design and development of biologics; research, design and development of combinations of diagnostics and biologics; research, design and development of kits for use in molecular biology applications.

Biological assays consisting primarily of monoclonal antibodies, pre-made buffer concentrates, and chemical reagents for clinical use and scientific research in the fields of biological and diagnostic testing for industrial, scientific and research use; biological tissue cultures for research and scientific diagnosis use; antibodies reagents for research and scientific diagnosis use; combinations of antibodies for clinical use and scientific research in the fields of biological and diagnostic testing for industrial, scientific and research use

Biological assays for medical use, namely, biological preparations for the treatment or prophylaxis of cancer; pharmaceutical preparations, namely biologics for the treatment or prophylaxis of infectious diseases; pharmaceutical preparations, namely, biologics and antibodies for the treatment of oncological disorders and conditions; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologic pharmaceutical preparations, namely, antibodies for use with diagnostic agents for the diagnosis of oncological diseases, disorders and conditions in humans; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease

Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use; antibodies for clinical, medical laboratory, or research use; combinations of antibodies for clinical, medical laboratory, or research use; kits containing buffers and reagents for research use

Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use; biologics for medical use, namely, medical diagnosis of diseases in humans and animals, namely, infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of infectious disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cancer; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of autoimmune/inflammatory disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of neurological disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of metabolic disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of respiratory disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of ophthalmic disease; biologics for medical use, namely, biological preparation for the treatment or prophylaxis of animal disease namely infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases; biologics, namely, vaccines for prophylaxis or treatment of human disease, namely infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases; biologics, namely, vaccines for prophylaxis or treatment of animal disease, namely infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases; combinations of biologics for medical use, namely, medical diagnosis of diseases in humans and animals, namely infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of autoimmune/inflammatory disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of neurological disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of metabolic disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of respiratory disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of ophthalmic disease; combinations of biologics for medical use, namely, biological preparation for the treatment or prophylaxis of animal disease, namely infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases; combinations of biologics, namely, vaccines for prophylaxis or treatment of human disease, namely infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases; combinations of biologics, namely, vaccines for prophylaxis of treatment or animal disease infectious diseases, cancer, autoimmune/inflammatory diseases, cardiovascular diseases, neurological diseases, metabolic diseases, respiratory diseases, ophthalmic diseases.